• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病与心血管疾病风险:所有炎症都会导致心脏病吗?

Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?

机构信息

Department of Medicine, University of Arizona, Phoenix, AZ, United States.

Department of Medicine, University of Miami at Holy Cross Hospital, Fort Lauderdale, FL, United States.

出版信息

Trends Cardiovasc Med. 2020 Nov;30(8):463-469. doi: 10.1016/j.tcm.2019.10.001. Epub 2019 Oct 11.

DOI:10.1016/j.tcm.2019.10.001
PMID:31653485
Abstract

Inflammation has a strong role in the development of atherosclerotic cardiovascular disease (ASCVD). Several systemic inflammatory conditions have been linked to an increased risk of ASCVD; however, this has not been well established in Inflammatory Bowel Disease (IBD). IBD is comprised of Ulcerative Colitis and Crohn's disease, both of which involve chronic inflammation of the intestinal tract, often with evidence of systemic involvement. Several ASCVD risk factors such as smoking, diabetes, poor diet and the presence of obesity may increase the risk of ASCVD in patients suffering from IBD, despite a lower prevalence of hypertension and hypercholesterolemia. Medications used to treat IBD and target inflammation, such as steroids, may also accelerate the risk of the risk for ASCVD heart failure while exacerbating ASCVD risk factors. Several studies have demonstrated an elevated risk of acute myocardial infarction and stroke in these patients, most notably in women and in younger patients. Some cohort studies have also suggested a link between IBD and both atrial fibrillation and heart failure, particularly during periods of active flares. All IBD patients, particularly younger individuals, should be screened for ASCVD risk factors with aggressive risk factor modification to reduce the risk of cardiovascular events. Further research is needed to identify how to prevent and treat cardiovascular events that occur in patients with IBD, particularly during active flares.

摘要

炎症在动脉粥样硬化性心血管疾病(ASCVD)的发展中起着重要作用。一些全身性炎症性疾病与 ASCVD 风险增加有关;然而,这在炎症性肠病(IBD)中尚未得到充分证实。IBD 包括溃疡性结肠炎和克罗恩病,两者都涉及肠道的慢性炎症,通常伴有全身受累的证据。一些 ASCVD 风险因素,如吸烟、糖尿病、不良饮食和肥胖的存在,可能会增加 IBD 患者患 ASCVD 的风险,尽管高血压和高胆固醇血症的患病率较低。用于治疗 IBD 并靶向炎症的药物,如类固醇,也可能加速 ASCVD 心力衰竭的风险,同时加剧 ASCVD 的风险因素。几项研究表明,这些患者的急性心肌梗死和中风风险增加,尤其是在女性和年轻患者中。一些队列研究还表明,IBD 与房颤和心力衰竭之间存在关联,特别是在活动期发作期间。所有 IBD 患者,尤其是年轻患者,应筛查 ASCVD 风险因素,并积极进行危险因素改变,以降低心血管事件的风险。需要进一步研究以确定如何预防和治疗 IBD 患者发生的心血管事件,特别是在活动期发作期间。

相似文献

1
Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?炎症性肠病与心血管疾病风险:所有炎症都会导致心脏病吗?
Trends Cardiovasc Med. 2020 Nov;30(8):463-469. doi: 10.1016/j.tcm.2019.10.001. Epub 2019 Oct 11.
2
Controlling leukocyte trafficking in IBD.控制炎症性肠病中的白细胞迁移。
Pharmacol Res. 2020 Sep;159:105050. doi: 10.1016/j.phrs.2020.105050. Epub 2020 Jun 26.
3
Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.门诊环境中艰难梭菌叠加感染对克罗恩病或溃疡性结肠炎发作的影响。
Int J Colorectal Dis. 2018 Sep;33(9):1285-1294. doi: 10.1007/s00384-018-3105-8. Epub 2018 Jun 21.
4
Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.炎症性肠病的过敏与免疫学观点。
Clin Rev Allergy Immunol. 2019 Oct;57(2):179-193. doi: 10.1007/s12016-018-8690-3.
5
Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study.炎症性肠病活动期增加心房颤动和中风的风险:一项全国性研究。
Europace. 2014 Apr;16(4):477-84. doi: 10.1093/europace/eut312. Epub 2013 Oct 9.
6
Advances in understanding the role of cytokines in inflammatory bowel disease.细胞因子在炎症性肠病中的作用研究进展。
Expert Rev Gastroenterol Hepatol. 2018 Sep;12(9):907-915. doi: 10.1080/17474124.2018.1503053. Epub 2018 Jul 30.
7
Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.氨基酸在炎症性肠病中的治疗潜力。
Nutrients. 2017 Aug 23;9(9):920. doi: 10.3390/nu9090920.
8
Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab.接受英夫利昔单抗治疗的炎症性肠病患者的反常关节表现。
Eur J Gastroenterol Hepatol. 2016 Aug;28(8):876-81. doi: 10.1097/MEG.0000000000000643.
9
The Search for Causative Environmental Factors in Inflammatory Bowel Disease.炎症性肠病致病环境因素的探寻
Dig Dis. 2016;34 Suppl 1:48-55. doi: 10.1159/000447283. Epub 2016 Aug 22.
10
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.瑞士炎症性肠病队列中因药物相关副作用而需要停药的频率及类型
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):612-620. doi: 10.1097/MEG.0000000000001078.

引用本文的文献

1
Effect of glucagon-like peptide-1 receptor agonists on major adverse cardiovascular events in patients with inflammatory bowel disease.胰高血糖素样肽-1受体激动剂对炎症性肠病患者主要不良心血管事件的影响。
Crohns Colitis 360. 2025 Aug 12;7(3):otaf056. doi: 10.1093/crocol/otaf056. eCollection 2025 Jul.
2
Hidradenitis Suppurativa: Beyond Skin Concerns to Focus on Cardiovascular Considerations.化脓性汗腺炎:超越皮肤问题,关注心血管方面的考量。
J Clin Aesthet Dermatol. 2025 Jul-Aug;18(7-8 Suppl 1):S10-S15.
3
Strategies for assessing and preventing cardiovascular disease risk in inflammatory bowel disease patients: A meta-analysis and meta-regression and bibliometric review.
评估和预防炎症性肠病患者心血管疾病风险的策略:一项荟萃分析、元回归分析和文献计量学综述
PLoS One. 2025 Jul 28;20(7):e0327734. doi: 10.1371/journal.pone.0327734. eCollection 2025.
4
Exploration of shared diagnostic genes and mechanisms between crohn's disease and ischemic stroke by integrated comprehensive bioinformatics analysis and machine learning.通过综合生物信息学分析和机器学习探索克罗恩病与缺血性中风之间的共同诊断基因及机制
Mamm Genome. 2025 Jun 30. doi: 10.1007/s00335-025-10145-9.
5
Trends and disparities in inflammatory bowel disease and cardiovascular disease-related mortality in the United States from 1999 to 2023: A CDC WONDER analysis.1999年至2023年美国炎症性肠病和心血管疾病相关死亡率的趋势与差异:疾病控制与预防中心的WONDER分析
Int J Cardiol Cardiovasc Risk Prev. 2025 May 22;26:200438. doi: 10.1016/j.ijcrp.2025.200438. eCollection 2025 Sep.
6
Colitis induced ventricular alternans increases the risk for ventricular arrhythmia.结肠炎诱发的心室交替变化增加了室性心律失常的风险。
J Mol Cell Cardiol. 2025 Jul;204:68-78. doi: 10.1016/j.yjmcc.2025.05.004. Epub 2025 May 21.
7
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease.靶向内源性大麻素系统:一种治疗炎症性肠病肠外并发症的新方法。
Pharmaceuticals (Basel). 2025 Mar 27;18(4):478. doi: 10.3390/ph18040478.
8
Analysis of the molecular mechanisms of ulcerative colitis and atherosclerosis by microarray data.利用微阵列数据分析溃疡性结肠炎和动脉粥样硬化的分子机制。
Sci Rep. 2025 Mar 28;15(1):10715. doi: 10.1038/s41598-025-95125-4.
9
Cardiac arrhythmia in patients with inflammatory bowel disease: a retrospective, population-based cohort study in Manitoba, Canada.炎症性肠病患者的心律失常:加拿大曼尼托巴省一项基于人群的回顾性队列研究。
BMJ Open. 2025 Mar 21;15(3):e097687. doi: 10.1136/bmjopen-2024-097687.
10
Casual effect of ulcerative colitis on chronic heart failure: results from a bidirectional Mendelian randomization study.溃疡性结肠炎对慢性心力衰竭的因果效应:一项双向孟德尔随机化研究的结果
BMC Gastroenterol. 2025 Feb 20;25(1):95. doi: 10.1186/s12876-025-03671-y.